Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy

The prognostic value of tumour-infiltrating lymphocytes (TILs) differs by breast cancer (BC) subtype. The aim of this study was to evaluate TILs in stage III BC in the context of BRCA1/2-like phenotypes and association with outcome and benefit of intensified platinum-based chemotherapy.

Source: European Journal of Cancer - January 15, 2020 Category: Cancer & Oncology Authors: Leonora de Boo, Ashley Cimino-Mathews, Yoni Lubeck, Antonios Daletzakis, Mark Opdam, Joyce Sanders, Erik Hooijberg, Annelot van Rossum, Zuzana Loncova, Dietmar Rieder, Zlatko Trajanoski, Marieke Vollebergh, Marcelo Sobral-Leite, Koen van de Vijver, Annegi Tags: Original Research Source Type: research